These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 3215246

  • 1. Hormonal consequences of orchidectomy for carcinoma of the prostate. With special reference to the measurement of free testosterone in saliva and prostatic dihydrotestosterone levels.
    Boccon-Gibod L, Laudat MH, Guiban D, Steg A.
    Eur Urol; 1988; 15(1-2):99-102. PubMed ID: 3215246
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Peripheral hormone levels in controls and patients with prostatic cancer or benign prostatic hyperplasia: results from the Dutch-Japanese case-control study.
    de Jong FH, Oishi K, Hayes RB, Bogdanowicz JF, Raatgever JW, van der Maas PJ, Yoshida O, Schroeder FH.
    Cancer Res; 1991 Jul 01; 51(13):3445-50. PubMed ID: 1711411
    [Abstract] [Full Text] [Related]

  • 4. Tissue and serum levels of principal androgens in benign prostatic hyperplasia and prostate cancer.
    Heracek J, Hampl R, Hill M, Starka L, Sachova J, Kuncova J, Eis V, Urban M, Mandys V.
    Steroids; 2007 Apr 01; 72(4):375-80. PubMed ID: 17368496
    [Abstract] [Full Text] [Related]

  • 5. The influence of androgen deprivation therapy on dihydrotestosterone levels in the prostatic tissue of patients with prostate cancer.
    Nishiyama T, Hashimoto Y, Takahashi K.
    Clin Cancer Res; 2004 Nov 01; 10(21):7121-6. PubMed ID: 15534082
    [Abstract] [Full Text] [Related]

  • 6. Influence of radical prostatectomy on serum hormone levels.
    Miller LR, Partin AW, Chan DW, Bruzek DJ, Dobs AS, Epstein JI, Walsh PC.
    J Urol; 1998 Aug 01; 160(2):449-53. PubMed ID: 9679896
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Intraprostatic testosterone and dihydrotestosterone. Part II: concentrations after androgen hormonal manipulation in men with benign prostatic hyperplasia and prostate cancer.
    van der Sluis TM, Meuleman EJ, van Moorselaar RJ, Bui HN, Blankenstein MA, Heijboer AC, Vis AN.
    BJU Int; 2012 Jan 01; 109(2):183-8. PubMed ID: 21992404
    [Abstract] [Full Text] [Related]

  • 9. Flutamide versus orchidectomy in the treatment of metastatic prostate carcinoma.
    Boccon-Gibod L, Fournier G, Bottet P, Marechal JM, Guiter J, Rischman P, Hubert J, Soret JY, Mangin P, Mallo C, Fraysse CE.
    Eur Urol; 1997 Jan 01; 32(4):391-5; discussion 395-6. PubMed ID: 9412794
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Testosterone-mediated increase in 5 alpha-dihydrotestosterone content, nuclear androgen receptor levels, and cell division in an androgen-independent prostate carcinoma of Noble rats.
    Ho SM, Leav I, Damassa D, Kwan PW, Merk FB, Seto HS.
    Cancer Res; 1988 Feb 01; 48(3):609-14. PubMed ID: 3257169
    [Abstract] [Full Text] [Related]

  • 13. [Testosterone in saliva: application to the follow-up of prostate cancer].
    Navarro-Moreno MA, Rivera-Coll A.
    Rev Esp Fisiol; 1990 Mar 01; 46(1):63-8. PubMed ID: 2204093
    [Abstract] [Full Text] [Related]

  • 14. The change in the dihydrotestosterone level in the prostate before and after androgen deprivation therapy in connection with prostate cancer aggressiveness using the Gleason score.
    Nishiyama T, Ikarashi T, Hashimoto Y, Wako K, Takahashi K.
    J Urol; 2007 Oct 01; 178(4 Pt 1):1282-8; discussion 1288-9. PubMed ID: 17698092
    [Abstract] [Full Text] [Related]

  • 15. Adrenal steroid levels in castrated men with prostatic carcinoma treated with aminoglutethimide plus hydrocortisone.
    Ahmann FR, Crawford ED, Kreis W, Levasseur Y.
    Cancer Res; 1987 Sep 01; 47(17):4736-9. PubMed ID: 3621171
    [Abstract] [Full Text] [Related]

  • 16. The baboon prostate as a model for steroid hormone receptors in the human gland.
    Karr JP, Kirdani RY, Murphy GP, Sandberg AA.
    Prog Clin Biol Res; 1979 Sep 01; 33():165-79. PubMed ID: 119228
    [No Abstract] [Full Text] [Related]

  • 17. [Inhibition of the free, biologically active testosterone level by Turisteron in patients with prostate cancer].
    Stahl F, Schnorr D, Rohde W, Dörner G.
    Z Urol Nephrol; 1987 Mar 01; 80(3):135-8. PubMed ID: 3604472
    [Abstract] [Full Text] [Related]

  • 18. Endogenous sex hormones and prostate cancer risk: a case-control study nested within the Carotene and Retinol Efficacy Trial.
    Chen C, Weiss NS, Stanczyk FZ, Lewis SK, DiTommaso D, Etzioni R, Barnett MJ, Goodman GE.
    Cancer Epidemiol Biomarkers Prev; 2003 Dec 01; 12(12):1410-6. PubMed ID: 14693730
    [Abstract] [Full Text] [Related]

  • 19. The effects of diethylstilbestrol and medroxyprogesterone acetate on kinetics and production of testosterone and dihydrotestosterone in patients with prostatic carcinoma.
    Nolten WE, Sholiton LJ, Srivastava LS, Knowles HC, Werk EE.
    J Clin Endocrinol Metab; 1976 Dec 01; 43(6):1226-33. PubMed ID: 1002814
    [Abstract] [Full Text] [Related]

  • 20. Subcapsular orchidectomy in the management of prostatic carcinoma in Nigerians.
    Magoha GA.
    East Afr Med J; 1989 Jun 01; 66(6):400-3. PubMed ID: 2791945
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.